DENVER— SmartTab, a digital drug delivery company based in Denver, Colorado developing a precision medicine technology platform of advanced ingestible capsules to deliver biologics and targeted medications announces it will participate in TechCrunch Disrupt 2021. The company will be meeting with potential investors and potential partners throughout the week.
SmartTab continues to focus on developing an oral ingestible capsule for the delivery of biologics and large molecules. InjectTab™ has the potential to revolutionize the treatment of self-injections with an ingestible capsule that delivers biologics, large molecules, and proteins internally to the stomach or upper GI areas. This advancement will allow painful injections via syringe and needle to be replaced by swallowing a capsule that injects active ingredients into the lining of the stomach.
In 2020, SmartTab was selected by TechCrunch (TC) editors as one of three TC Top Picks in the category of Biotech & Healthtech for their TechCrunch Disrupt annual tech conference. TechCrunch is an American online publisher with in-depth understanding and reporting on tech business, technology, analysis of emerging trends, and profiling of new tech businesses and products.
SmartTab Founder/CEO, Robert Niichel, sat down with TechCrunch editors last year to introduce their latest invention InjectTab™. TechCrunch Disrupt is one of the world's largest innovative tech startup conferences held annually by TechCrunch since 2011.
"TechCrunch Disrupt is a great way to share our mission to bring Patient-Centered Drug Delivery Systems to market and network with established investors and spark collaboration our fellow leaders in tech."
–Robert Niichel, SmartTab, Founder/CEO
Going to TechCrunch Disrupt this year? Visit the SmartTab virtual booth in the Expo section.
